이상반응 보고
| VAERS ID | 984528 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | PA |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | |
| 발병일 | |
| 상태 |
증상
- 모유를 통한 노출(Exposure via breast milk)
- 월경 불규칙(Menstruation irregular)
이환 중 질병
지병
Medical History/Concurrent Conditions: Absence of menstruation
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
one woman has been breastfeeding; early menses after receiving the vaccine; This is a spontaneous report from a Pfizer sponsored program, from a contactable consumer.
This consumer reported information for both mother and baby.
This is the maternal report.
A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization.
Medical history included "has not had a period since 2019".
The patient's concomitant medications were not reported.
The patient had early menses after receiving the vaccine.
She has been breastfeeding.
Outcome of the event "early menses after receiving the vaccine" was unknown.
Information on lot number/batch number was requested.